Skip to content

Goodwill at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$48.56B+9.2%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$3.89B+0.6%
Glaukos logo
GlaukosGKOS
$66.71M+0.9%
AbbVie logo
AbbVieABBV
$35.57B+0.8%
Organon logo
OrganonOGN
$4.15B-11.3%
Solventum logo
SolventumSOLV
$5.63B+12.7%

Segments

By segment

See full
Vision Care$3.55B+0.4%
Pharmaceuticals$731M+8.0%
Surgical$456M+28.5%

Other financials

Income statement

See full
Revenue$1.2B+9.4%
Operating income$33.0M+140%
Net income-$71.0M+66.5%
EPS (diluted)-$0.20+66.7%

Balance sheet

See full
Cash & equivalents$279.0M+29.8%
Total debt$5.0B+4.3%
Total equity$6.4B+0.3%
Total assets$13.8B+2.6%

Cash flow

See full
Operating cash flow$32.0M+228%
CapEx$100.0M-9.1%
Free cash flow-$68.0M+49.6%

Valuation

See full
Market cap$5.43B+10.2%

Profitability

See full
Operating margin4.4%+2.9pp
Net margin-4.2%-1.3pp
FCF margin-3.4%0.0pp

Returns & leverage

See full
Return on equity-3.4%-0.9pp
Debt / equity0.8×0.0×
Current ratio1.5×0.0×

Where this comes from

Reported directly by Bausch + Lomb in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Bausch + Lomb’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch + Lomb's goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch + Lomb's goodwill?
Bausch + Lomb (BLCO) reported goodwill of $4.74B in Q1 2026.
How has Bausch + Lomb's goodwill changed year-over-year?
Bausch + Lomb's goodwill increased by 3.7% year-over-year, from $4.57B to $4.74B.
What is the long-term trend for Bausch + Lomb's goodwill?
Over 5 years (2020 to 2025), Bausch + Lomb's goodwill has grown at a 0.3% compound annual growth rate (CAGR), from $4.69B to $4.76B.
What does goodwill mean?
The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.